Harnessing the therapeutic potential therapeutic efficacy of α-1 adrenergic blockers for Raynaud’s phenomenon and digital ischaemia secondary to central nervous system stimulants used for attention deficit hyperactivity disorder

Michael Hughes; Hafiz M. Umair; Robert D Sandler; Alessia Alunno; Marco Matucci-Cerinic

doi:10.1016/j.semarthrit.2022.152114

Harnessing the therapeutic potential therapeutic efficacy of α-1 adrenergic blockers for Raynaud’s phenomenon and digital ischaemia secondary to central nervous system stimulants used for attention deficit hyperactivity disorder

Michael Hughes^*, Hafiz M. Umair, Robert D Sandler, Alessia Alunno, Marco Matucci-Cerinic

^*Corresponding author for this work

Division of Musculoskeletal & Dermatological Sciences (L5)

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	152114
Journal	Seminars in arthritis and rheumatism
Volume	57
Early online date	21 Oct 2022
DOIs	https://doi.org/10.1016/j.semarthrit.2022.152114
Publication status	Published - 1 Dec 2022

Access to Document

10.1016/j.semarthrit.2022.152114

Cite this

Hughes, M., Umair, H. M., Sandler, R. D., Alunno, A., & Matucci-Cerinic, M. (2022). Harnessing the therapeutic potential therapeutic efficacy of α-1 adrenergic blockers for Raynaud’s phenomenon and digital ischaemia secondary to central nervous system stimulants used for attention deficit hyperactivity disorder. Seminars in arthritis and rheumatism, 57, Article 152114. https://doi.org/10.1016/j.semarthrit.2022.152114

@article{8d04de18b6fd4aafa15d80499aecaca2,

title = "Harnessing the therapeutic potential therapeutic efficacy of α-1 adrenergic blockers for Raynaud{\textquoteright}s phenomenon and digital ischaemia secondary to central nervous system stimulants used for attention deficit hyperactivity disorder",

author = "Michael Hughes and Umair, {Hafiz M.} and Sandler, {Robert D} and Alessia Alunno and Marco Matucci-Cerinic",

year = "2022",

month = dec,

day = "1",

doi = "10.1016/j.semarthrit.2022.152114",

language = "English",

volume = "57",

journal = "Seminars in arthritis and rheumatism",

issn = "0049-0172",

publisher = "W.B. Saunders Company",

}

Hughes, M, Umair, HM, Sandler, RD, Alunno, A & Matucci-Cerinic, M 2022, 'Harnessing the therapeutic potential therapeutic efficacy of α-1 adrenergic blockers for Raynaud’s phenomenon and digital ischaemia secondary to central nervous system stimulants used for attention deficit hyperactivity disorder', Seminars in arthritis and rheumatism, vol. 57, 152114. https://doi.org/10.1016/j.semarthrit.2022.152114

Harnessing the therapeutic potential therapeutic efficacy of α-1 adrenergic blockers for Raynaud’s phenomenon and digital ischaemia secondary to central nervous system stimulants used for attention deficit hyperactivity disorder. / Hughes, Michael; Umair, Hafiz M.; Sandler, Robert D et al.
In: Seminars in arthritis and rheumatism, Vol. 57, 152114, 01.12.2022.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Harnessing the therapeutic potential therapeutic efficacy of α-1 adrenergic blockers for Raynaud’s phenomenon and digital ischaemia secondary to central nervous system stimulants used for attention deficit hyperactivity disorder

AU - Hughes, Michael

AU - Umair, Hafiz M.

AU - Sandler, Robert D

AU - Alunno, Alessia

AU - Matucci-Cerinic, Marco

PY - 2022/12/1

Y1 - 2022/12/1

UR - http://www.scopus.com/inward/record.url?scp=85141428038&partnerID=8YFLogxK

U2 - 10.1016/j.semarthrit.2022.152114

DO - 10.1016/j.semarthrit.2022.152114

M3 - Letter

C2 - 36356481

AN - SCOPUS:85141428038

SN - 0049-0172

VL - 57

JO - Seminars in arthritis and rheumatism

JF - Seminars in arthritis and rheumatism

M1 - 152114

ER -

Hughes M, Umair HM, Sandler RD, Alunno A, Matucci-Cerinic M. Harnessing the therapeutic potential therapeutic efficacy of α-1 adrenergic blockers for Raynaud’s phenomenon and digital ischaemia secondary to central nervous system stimulants used for attention deficit hyperactivity disorder. Seminars in arthritis and rheumatism. 2022 Dec 1;57:152114. Epub 2022 Oct 21. doi: 10.1016/j.semarthrit.2022.152114

Harnessing the therapeutic potential therapeutic efficacy of α-1 adrenergic blockers for Raynaud’s phenomenon and digital ischaemia secondary to central nervous system stimulants used for attention deficit hyperactivity disorder

Access to Document

Other files and links

Cite this